| Literature DB >> 8341396 |
D Paulsen1, A Reisoether, M Aasen, P Fauchald.
Abstract
The use of central venous catheters as permanent vascular access in chronic hemodialysis is complicated by clotting. We have tried a nonallergenic thrombolytic agent, tissue plasminogen activator (t-PA), to dissolve catheter luminal thrombosis. Eight patients, 7 in chronic hemodialysis and 1 treated by immune adsorption had 18 treatments with locally applied t-PA (2 mg/2 cm3). Fifteen out of 16 treatments with longer bolus dwell than 60 min were successful. No side effects occurred. t-PA dissolves clot formation efficiently and safely, the drug is nonallergenic and can therefore be given repeatedly.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8341396 DOI: 10.1159/000187374
Source DB: PubMed Journal: Nephron ISSN: 1660-8151 Impact factor: 2.847